Tech Company Financing Transactions
Impel NeuroPharma Funding Round
Private investors participated in a $1.1 million capital raise for Impel NeuroPharma. The financing round was announced by the company on 8/31/2016.
Transaction Overview
Company Name
Announced On
8/31/2016
Transaction Type
Debt
Amount
$1,090,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
201 Elliott Ave. West 260
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jon Congleton
Chief Medical Officer
Stephen Shrewsbury
Chief Scientific Officer
John Hoekman
Vice President
Michael Malafronte
VP - Bus. Development
Ellen Lubman
VP - Engineering
Scott Youmans
VP - Operations
Meghan Swardstrom
VP - Regulatory Affairs
Lynn Gold
Browse more venture capital transactions:
Prev: 8/31/2016: Petnet venture capital transaction
Next: 8/31/2016: Honest Buildings venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs